NasdaqGM - Nasdaq Real Time Price USD

CRISPR Therapeutics AG (CRSP)

41.90
+3.33
+(8.64%)
As of 12:44:47 PM EDT. Market Open.
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-306,473
-142,774
-260,375
-495,741
538,972
Investing Cash Flow
-202,436
-280,481
374,647
-258,655
-1,035,430
Financing Cash Flow
36,638
331,984
62,664
38,592
250,945
End Cash Position
246,672
309,776
401,068
224,060
939,944
Capital Expenditure
-1,386
-1,901
-11,970
-37,188
-81,705
Issuance of Capital Stock
28,466
300,695
32,721
970
213,267
Free Cash Flow
-307,859
-144,675
-272,345
-532,929
457,267
12/31/2021 - 10/19/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NTLA Intellia Therapeutics, Inc.
8.36
+10.22%
 
BEAM Beam Therapeutics Inc.
18.85
+10.88%
 
VRTX Vertex Pharmaceuticals Incorporated
448.23
+0.99%
 
EDIT Editas Medicine, Inc.
1.9450
+8.04%
 
RXRX Recursion Pharmaceuticals, Inc.
5.45
+19.27%
 
REGN Regeneron Pharmaceuticals, Inc.
496.21
+2.72%
 
MRNA Moderna, Inc.
27.15
+3.92%
 
VKTX Viking Therapeutics, Inc.
27.86
+3.03%
 
VERV Verve Therapeutics, Inc.
6.57
+14.66%
 
SMMT Summit Therapeutics Inc.
21.00
+6.44%